An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer
Public ClinicalTrials.gov record NCT02632409. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab Versus Placebo in Subjects With High Risk Invasive Urothelial Carcinoma (CheckMate 274: CHECKpoint Pathway and nivoluMAb Clinical Trial Evaluation 274)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the effectiveness and safety of Nivolumab compared to placebo in participants who have undergone radical surgery for invasive urothelial cancer.
Study identification
- NCT ID
- NCT02632409
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 709 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 22, 2016 (Actual)
- Primary completion
- Jul 17, 2020 (Actual)
- Completion
- May 19, 2026 (Actual)
- Last update posted
- Jul 30, 2026
2016 – 2026
United States locations
- U.S. sites
- 33
- U.S. states
- 19
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alaska Urological Institute dba Alaska Clinical Research Center | Anchorage | Alaska | 99503 | — |
| Local Institution - 0179 | Tucson | Arizona | 85704 | — |
| Local Institution - 0061 | Clovis | California | 93611 | — |
| Local Institution - 0172 | Sacramento | California | 95817 | — |
| Local Institution - 0005 | San Francisco | California | 94115 | — |
| Local Institution - 0178 | Lakewood | Colorado | 80228 | — |
| Local Institution - 0167 | Gainesville | Florida | 32610 | — |
| Local Institution - 0030 | Miami Beach | Florida | 33140 | — |
| Local Institution - 0008 | Tampa | Florida | 33612 | — |
| Local Institution - 0168 | Maywood | Illinois | 60153 | — |
| Local Institution - 0094 | Fort Wayne | Indiana | 46804 | — |
| Local Institution - 0171 | New Orleans | Louisiana | 70112 | — |
| Local Institution - 0173 | Grand Rapids | Michigan | 49503 | — |
| Local Institution - 0051 | Burnsville | Minnesota | 55337 | — |
| Local Institution - 0004 | Rochester | Minnesota | 55905 | — |
| Local Institution - 0003 | Omaha | Nebraska | 68130 | — |
| Local Institution - 0177 | Las Vegas | Nevada | 89148 | — |
| Local Institution - 0176 | Albany | New York | 12208 | — |
| Local Institution - 0157 | Buffalo | New York | 14263 | — |
| Local Institution - 0007 | Mineola | New York | 11501 | — |
| Local Institution - 0001 | New York | New York | 10021 | — |
| Local Institution - 0006 | New York | New York | 10029 | — |
| Local Institution - 0166 | Chapel Hill | North Carolina | 27599-7305 | — |
| Local Institution | Durham | North Carolina | 27708 | — |
| Local Institution - 0044 | Portland | Oregon | 97213 | — |
| Local Institution - 0010 | Portland | Oregon | 97239 | — |
| Local Institution - 0180 | Tigard | Oregon | 97223 | — |
| Local Institution - 0074 | Allentown | Pennsylvania | 18103 | — |
| Local Institution - 0011 | Pittsburgh | Pennsylvania | 15212 | — |
| Local Institution - 0040 | Pittsburgh | Pennsylvania | 15232 | — |
| Local Institution - 0169 | Myrtle Beach | South Carolina | 29572 | — |
| Local Institution - 0009 | Chattanooga | Tennessee | 37404 | — |
| Local Institution - 0234 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 155 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02632409, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 30, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02632409 live on ClinicalTrials.gov.